Used in the development of pharmaceutical compounds, particularly as a key intermediate in the synthesis of biologically active molecules. Its structure is valuable in creating inhibitors for specific enzymes, making it relevant in drug discovery for treating diseases like cancer or inflammatory disorders. The trifluoromethyl groups enhance binding affinity and metabolic stability, while the piperidinyl and cyclohexyl moieties contribute to target specificity. It is also explored in medicinal chemistry for its potential to modulate protein-protein interactions, offering a pathway for novel therapeutic agents.